INS and Hyperglycemia: Autoantibodies targeting cytoplasmic components of pancreatic islets—such as glutamic acid decarboxylase (GAD), insulin, and tyrosine phosphatase proteins (IA-2/IA-2β)—can be detected months to years before the onset of hyperglycemia.